The Manila Times

Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company”, "Opus Genetics” or "Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...
The Manila Times

Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Fish Oil Supplements May Not Help Stave Off Dementia After All

A large-scale clinical trial has shown that even long-term consumption of DHA—an omega-3 fatty acid found in abundance in ...
IEEE

A Three-Way Decision Methodology With Regret Theory via Triangular Fuzzy Numbers in Incomplete Multiscale Decision Information Systems

Abstract: The three-way decision theory provides a three-way philosophical thinking to solve problems, and the regret theory quantifies the risk preferences of decision makers under different ...
SciELO

A New Triangular Hybrid Displacement Function Element for Static and Free Vibration Analyses of Mindlin-Reissner Plate

Finite element method; Mindlin-Reissner plate element; hybrid displacement function element method; modified principle of complementary energy; static and free vibration analyses By employing similar ...
IEEE

Triangular-domain basis functions for full-wave analysis of microstrip discontinuities

Abstract: A numerical technique for computing the S-parameters of arbitrarily shaped microstrip discontinuities and interconnects is presented. The microstrip conducting surface is rendered in a ...